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Background
The Lassa Virus is an endemic disease to West Africa, 
especially Guinea, Liberia, Sierra Leone, and parts of 
Nigeria.  The virus is of the member arenaviridae and 
according to the World Health Organization affects between 
300,000 to 500,000 annually with a death toll of about 
5,000 per year.  It causes the Lassa Fever which affects 
almost every system in the body, although fever is the most 
obvious and common symptom.  The vector is the rodent 
from the Mastomys genus that is known as the 
"multimammate rat“.  This rodent is easily recognizable 
because of its hairless tail and the number of cases is 
directly proportional to the abundance of this rodent.   The 
outlined program will be presented for adoption to the 
HEART not-for-profit Organization, as well as Teva 
Pharmaceuticals.
Lassa Virus Prevention in West Africa
Great Problem Seminar: Heal the World
Mikaela Gordon, Morley DuPuy, and Jirom Yibrah
Treatment
The easiest way to test for the Lassa Virus would be to 
isolate it from the blood, urine, or throat washings.
Adults can take 2 gm of ribavirin as a first dosage, 
followed by 1 gm every six hours for four days.  For the six 
succeeding days, they should take 0.5 gm every eight 
hours.
Antibiotics are also useful for patients who are 
experiencing secondary bacterial infections.
Ribavirin is twice as effective when taken intravenously 
as opposed to orally.
Education
Program focuses on the people in endemic areas of 
West Africa 
Education on disease prevention as well 
as management.
Develop and host specific lectures, workshops, 
seminars for the general public
Educate the public about the cause of Lassa virus, 
how it is spread and how to prevent it. 
Teach them the symptoms. 
People living in endemic areas of West Africa with 
high populations of rodents are most at risk of Lassa 
fever.
Educate the people on the treatments available. 
Prevention by rodent control 
Do not kill the rat that will cause them to reproduce at 
a faster rate.
Identify wild Mastomys rats, which shed the virus in 
their urine and droppings. 
Transmission to humans occurs through 
Conclusion/Evaluation
The hypothesis was correct, as when HEART not-for-profit 
Organization was contacted, they decided not to adopt our 
program at this time.  Their reason was that there are more 
pressing issues at this time and because the Lassa Virus does 
not cause as many fatalities as HIV/AIDS, Mr. Sirleaf, the 
chairman of HEART said that it was not vital enough to include 
Proposal/Hypothesis
Project Statement: To outline a program focused on 
eradication of the Lassa virus through prevention with a 
concentration on education.  The program will be 
presented for adoption to the HEART not-for-profit 
Organization, as well as Teva Pharmaceuticals.
Hypothesis: It was preconceived that the proposal would 
not be immediately accepted because the Lassa Virus is a 
relatively new disease (recognized in 1969) and has not 
had as great of an effect as for example, malaria or 
HIV/AIDS.
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contamination of broken skin or mucous membranes 
via direct or indirect contact with infected rodent 
excreta, on floors, home surfaces, in food or water.
At Home:
•Frequent hand washing (during a VHF outbreak).
•Safe Burial Practices.
Anywhere:
•Washing hands before applying disinfectant is highly 
recommended because of its effectiveness.
it into their program.
While the Lassa Virus might not be a pressing issue at the 
moment, it is preconceived that it will be in the future.  So while 
it is pertinent to tackle current issues, it is also important not to 
overlook what could become very serious in the future.
